Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Founded in 2021, Isomorphic Labs is a subsidiary of Google parent Alphabet. It is currently preparing to dose the first patients with the AI-engineered drug in clinical trials and is “staffing up” ...

Sir Demis Hassabis said it feels like a recognition that AI is mature enough now to help with scientific discovery. Read more at straitstimes.com. Read more at straitstimes.com.